Furthermore, low SAMD9 expression was correlated with Glioma CpG island methylator phenotype (G-CIMP) (Fig. S2C), and significant differences were observed between primary and secondary tumors (Fig. S2D). Here, SAMD9 is linked to central nervous system cancer.